Acadia Pharmaceuticals reported $-14789000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Cara Therapeutics CARA:US $ -1013000 29.73M
Cytokinetics CYTK:US $ -76.09M 14.53M
Eisai 4523:JP Y 5564M 50219M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
Johnson & Johnson JNJ:US $ 8058M 282M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Moderna Inc MRNA:US 3.55B 489M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Prothena PRTA:US $ 109.2M 81.3M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Vanda Pharmaceuticals VNDA:US $ 10.72M 1.88M
Zogenix ZGNX:US $ -58M 0.89M